GeneDx Holdings Corp.
WGS
$98.01
$0.740.76%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 5.44M | -8.31M | -29.17M | -20.24M | -25.77M |
Total Depreciation and Amortization | 4.66M | 5.93M | 5.22M | 5.25M | -506.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | 2.60M |
Total Other Non-Cash Items | -5.52M | 3.74M | 23.00M | 6.26M | 2.19M |
Change in Net Operating Assets | -7.76M | -5.75M | -3.55M | -7.68M | -8.36M |
Cash from Operations | -3.18M | -4.40M | -4.51M | -16.41M | -29.86M |
Capital Expenditure | -3.05M | -646.00K | -1.35M | -443.00K | -2.38M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 147.00K |
Cash Acquisitions | -- | -- | -- | -- | 0.00 |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 2.53M | -7.11M | -21.35M | 1.29M | -2.64M |
Cash from Investing | -519.00K | -7.76M | -22.70M | 843.00K | -4.86M |
Total Debt Issued | -- | -- | -- | -- | 48.55M |
Total Debt Repaid | -1.53M | -707.00K | -528.00K | -462.00K | -1.47M |
Issuance of Common Stock | 32.55M | 14.68M | 137.00K | 24.00K | 19.00K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 31.02M | 13.97M | -391.00K | -438.00K | 47.10M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 27.32M | 1.82M | -27.60M | -16.01M | 12.38M |